Publications by authors named "Eike Steidl"

Claim this Profile
S
Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures.
Pinar Cakmak, Jennifer H Lun, Aakanksha Singh, Jadranka Macas, Jonathan Schupp, Eike Steidl

Immunity· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma.
Katharina Johanna Weber, Mareike Dettki, Marco Münzberg, Pia Susann Zeiner, Marie-Thérèse Forster, Eike Steidl

Acta Neuropathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Noninvasive High-Resolution In Vivo pH Mapping in Brain Tumors by P-Informed deepCEST MRI.
Jan-Rüdiger Schüre, Junaid Rajput, Manoj Shrestha, Ralf Deichmann, Elke Hattingen, Eike Steidl

NMR Biomed· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological tissue changes in brain tumors affect the pH-sensitivity of the T1-corrected apparent exchange dependent relaxation (AREX) of the amide protons.
Eike Steidl, Elisabeth Neuhaus, Manoj Shrestha, Ralf Deichmann, Katharina Weber

NMR Biomed· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Michael C Burger, Marie-Therese Forster, Annette Romanski, Florian Straßheimer, Jadranka Macas, Eike Steidl

Neuro Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma.
Iris Divé, Katharina J Weber, Tabea I Hartung, Eike Steidl, Marlies Wagner

Neurooncol Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topographic Mapping of Isolated Thalamic Infarcts Using Vascular and Novel Probabilistic Functional Thalamic Landmarks.
Maximilian Rauch, Jan-Rüdiger Schüre, Franziska Lieschke, Fee Keil, Eike Steidl

Clin Neuroradiol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Acute Superficial Siderosis Syndrome - Clinical Entity, Imaging Findings, and Histopathology.
Lucie Friedauer, Christian Foerch, Joachim Steinbach, Elke Hattingen, Patrick N Harter, Eike Steidl

Cerebellum· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma.
Eike Steidl, Katharina Filipski, Elke Hattingen, Joachim P Steinbach, Gabriele D Maurer

PLoS One· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.
Marguerite Müller, Oliver Winz, Robin Gutsche, Ralph T H Leijenaar, Martin Kocher, Eike Steidl

J Neurooncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study.
Eike Steidl, Maximilian Rauch, Elke Hattingen, Stella Breuer, Jan Rüdiger Schüre

Front Neurol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization.
Hans Urban, Eike Steidl, Elke Hattingen, Katharina Filipski, Markus Meissner

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
Eike Steidl, Katharina Filipski, Pia S Zeiner, Marlies Wagner, Emmanouil Fokas

J Cancer Res Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Prospective Analysis of Hypertrophic Olivary Degeneration Following Infratentorial Stroke (HOD-IS): Evaluation of Disease Epidemiology, Clinical Presentation, and MR-Imaging Aspects.
Martin A Schaller-Paule, Eike Steidl, Manoj Shrestha, Ralf Deichmann, Helmuth Steinmetz

Front Neurol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential implementation of DSC-MR perfusion and dynamic [F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.
Eike Steidl, Karl-Josef Langen, Sarah Abu Hmeidan, Nenad Polomac, Christian P Filss

Eur J Nucl Med Mol Imaging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
Iris Divé, Eike Steidl, Marlies Wagner, Katharina Filipski, Michael C Burger

Oncology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus Injury.
Martin A Schaller-Paule, Peter Baumgarten, Volker Seifert, Marlies Wagner, Eike Steidl

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients.
Pia S Zeiner, Martina Kinzig, Iris Divé, Gabriele D Maurer, Katharina Filipski, Eike Steidl

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab.
Martin Voss, AbdulAziz Batarfi, Eike Steidl, Marlies Wagner, Marie-Thérèse Forster

J Clin Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study.
Eike Steidl, Mathias Müller, Andreas Müller, Ulrich Herrlinger, Elke Hattingen

J Neurooncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoencephalopathy with occipital lobe epilepsy in an OPA-1 mutation carrier.
Robert Daniel Nass, Niels Hansen, Carlos Quesada, Theodor Rüber, Cornelia Kornblum, Eike Steidl

Seizure· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early diagnosis in a case of atypically located germinoma: H-MR-spectroscopy as a decision tool.
Eike Steidl, Valentina Zschernack, Frank Träber, Niklas Schäfer

Oxf Med Case Reports· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
Eike Steidl, Ulrich Pilatus, Elke Hattingen, Joachim P Steinbach, Friedhelm Zanella

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis